Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	26.18M
Revenue (ttm)	71.39M
Net Income (ttm)	1.72M
Shares Out	2.64B
EPS (ttm)	0.06
PE Ratio	0.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,024
Average Volume	73,020
Open	0.0104
Previous Close	0.0044
Day's Range	0.0086 - 0.0109
52-Week Range	0.0006 - 0.0111
Beta	-2.49
RSI	53.80
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company is based in Nashville, Tennessee.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Employees: 383
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS

Financial Performance

In 2010, Lotus Pharmaceuticals's revenue was $72.70 million, an increase of 28.71% compared to the previous year's $56.48 million. Earnings were $14.42 million, a decrease of -12.22%.